Published in Am J Surg Pathol on August 01, 1984
Definition of Barrett's esophagus dysplasia: are we speaking the same language? World J Surg (2015) 1.50
Barrett's esophagus. Correlation between mucin histochemistry, flow cytometry, and histologic diagnosis for predicting increased cancer risk. Am J Pathol (1988) 1.10
Barrett's esophagus: Incidence, etiology, pathophysiology, prevention and treatment. Ther Clin Risk Manag (2007) 1.00
Barrett esophagus: histology and pathology for the clinician. Nat Rev Gastroenterol Hepatol (2009) 0.95
Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China. World J Gastroenterol (2003) 0.95
Prevalence of Barrett's esophagus in Hispanics is similar to Caucasians. Dig Dis Sci (1998) 0.94
Use of a novel monoclonal antibody in diagnosis of Barrett's esophagus. Dig Dis Sci (2000) 0.92
Comparison of reflux esophagitis and its complications between African Americans and non-Hispanic whites. World J Gastroenterol (2009) 0.87
Squamous cell carcinoma in Barrett's esophagus: field effect versus metastasis. Dis Esophagus (2012) 0.80
Clinicopathological characterisation of small (2 cm or less) proximal and distal gastric carcinomas in a Chinese population. Pathology (2015) 0.78
Glycoconjugate expression in normal, metaplastic, and neoplastic human upper gastrointestinal mucosa. J Clin Invest (1987) 0.78
Columnar epithelial lined oesophagus (CELO) or Barrett's oesophagus: mucin histochemistry, dysplasia, and invasive adenocarcinoma. J Clin Pathol (1985) 0.78
Carcinoma of the gastroesophageal junction in Chinese patients. World J Gastroenterol (2012) 0.77
Early and late results of the acid suppression and duodenal diversion operation in patients with barrett's esophagus: analysis of 210 cases. World J Surg (2002) 0.77
Benign endoscopic biopsies may be a red herring. BMJ Case Rep (2009) 0.75
Unique Clinicopathology of Proximal Gastric Carcinoma: A Critical Review. Gastrointest Tumors (2014) 0.75
[Barrett's esophagus. An update]. Pathologe (2012) 0.75
Diagnosis and Surveillance of Barrett's Esophagus: Addressing the Transatlantic Divide. Dig Dis Sci (2016) 0.75
Genetic alterations during colorectal-tumor development. N Engl J Med (1988) 26.82
Clues to the pathogenesis of familial colorectal cancer. Science (1993) 14.52
Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science (1989) 11.53
Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A (1998) 9.66
Gene expression profiles in normal and cancer cells. Science (1997) 9.65
APC mutations occur early during colorectal tumorigenesis. Nature (1992) 9.50
Prevalence of ras gene mutations in human colorectal cancers. Nature (1987) 9.23
Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet (1994) 8.34
Identification of a chromosome 18q gene that is altered in colorectal cancers. Science (1990) 8.32
Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol (1983) 8.24
Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci U S A (1987) 7.12
Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem Biophys Res Commun (1985) 6.57
Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Science (1991) 6.15
Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med (1993) 6.13
Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res (1999) 6.10
Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med (2000) 5.68
A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst (1997) 5.68
Allelotype of colorectal carcinomas. Science (1989) 5.54
Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med (2001) 5.22
Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med (1994) 5.12
Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med (1996) 4.87
Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet (1997) 4.86
The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med (1997) 4.66
Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med (1987) 4.55
KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat Genet (1997) 4.46
Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol (1994) 4.43
Clonal analysis using recombinant DNA probes from the X-chromosome. Cancer Res (1987) 4.25
Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet (1996) 4.09
Molecular diagnosis of familial adenomatous polyposis. N Engl J Med (1993) 4.07
Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet (1995) 4.01
Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg (1991) 3.88
Clonal analysis of human colorectal tumors. Science (1987) 3.72
Hypomethylation of DNA from benign and malignant human colon neoplasms. Science (1985) 3.72
Identification of p53 gene mutations in bladder cancers and urine samples. Science (1991) 3.68
The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology (1992) 3.59
Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science (1992) 3.58
Mismatch repair deficiency in phenotypically normal human cells. Science (1995) 3.55
Top-down morphogenesis of colorectal tumors. Proc Natl Acad Sci U S A (2001) 3.51
The APC gene product in normal and tumor cells. Proc Natl Acad Sci U S A (1993) 3.25
Corticosteroid therapy of alcoholic hepatitis. Gastroenterology (1978) 3.21
Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res (1995) 3.13
Association between CpG island methylation and microsatellite instability in colorectal cancer. Cancer Res (1997) 3.09
Genetic instability occurs in the majority of young patients with colorectal cancer. Nat Med (1995) 3.07
Ischemic injury in the cat small intestine: role of superoxide radicals. Gastroenterology (1982) 2.95
Detecting colorectal cancer in stool with the use of multiple genetic targets. J Natl Cancer Inst (2001) 2.93
Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nat Med (1998) 2.91
Histopathological identification of colon cancer with microsatellite instability. Am J Pathol (2001) 2.90
Inhibition of apoptosis during development of colorectal cancer. Cancer Res (1995) 2.77
An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol (1994) 2.67
Petrosal approach for petroclival meningiomas. Neurosurgery (1988) 2.66
Molecular determinants of dysplasia in colorectal lesions. Cancer Res (1994) 2.62
Necrosis of the gastrointestinal tract in uremic patients as a result of sodium polystyrene sulfonate (Kayexalate) in sorbitol: an underrecognized condition. Am J Surg Pathol (1997) 2.57
Mad-related genes in the human. Nat Genet (1996) 2.51
Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors. Science (1985) 2.49
hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res (1994) 2.39
Choledochal cyst disease. A changing pattern of presentation. Ann Surg (1994) 2.33
The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. Am J Clin Pathol (1987) 2.31
Clinical and pathological associations with allelic loss in colorectal carcinoma [corrected]. JAMA (1989) 2.29
Prospective, randomized trial of autotransfusion after routine cardiac operations. Ann Thorac Surg (1993) 2.09
Desmoid tumours in familial adenomatous polyposis. Gut (1994) 2.08
Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease. Gastroenterology (1984) 2.08
Intestinal necrosis due to sodium polystyrene (Kayexalate) in sorbitol enemas: clinical and experimental support for the hypothesis. Surgery (1987) 2.07
High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer. Proc Natl Acad Sci U S A (1991) 2.07
Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum Pathol (1988) 2.03
Chronic colitis with thickening of the subepithelial collagen layer (collagenous colitis): histopathologic findings in 15 patients. Hum Pathol (1987) 1.97
Increased cytosine DNA-methyltransferase activity during colon cancer progression. J Natl Cancer Inst (1993) 1.94
Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. Am J Pathol (1997) 1.93
Budd-Chiari syndrome: etiology, diagnosis and management. Medicine (Baltimore) (1982) 1.92
Hepatoblastoma and APC gene mutation in familial adenomatous polyposis. Gut (1996) 1.89
CpG island methylation in colorectal adenomas. Am J Pathol (2001) 1.88
The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Gastroenterology (1995) 1.86
Phenotypic and molecular characteristics of hyperplastic polyposis. Gastroenterology (2000) 1.86
Variable phenotype of familial adenomatous polyposis in pedigrees with 3' mutation in the APC gene. Gut (1998) 1.85
Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut (1993) 1.85
The long-term side effects of radiation therapy for benign brain tumors in adults. J Neurosurg (1990) 1.83
Sarcoidosis and chronic hepatic disease: a clinical and pathologic study of 20 patients. Medicine (Baltimore) (1970) 1.82
Colorectal neoplasia in juvenile polyposis or juvenile polyps. Arch Dis Child (1991) 1.81
Prevalence and importance of pigmented ocular fundus lesions in Gardner's syndrome. N Engl J Med (1987) 1.76
Inactivation of both APC alleles in human and mouse tumors. Cancer Res (1994) 1.75
Surgical management of Crohn's disease. Influence of disease at margin of resection. Ann Surg (1980) 1.75
Visual loss as a complication of spine surgery. A review of 37 cases. Spine (Phila Pa 1976) (1997) 1.75
Pathogenesis of adenocarcinoma in Peutz-Jeghers syndrome. Cancer Res (1998) 1.73
Sources of nonlinearity in cDNA microarray expression measurements. Genome Biol (2001) 1.70
General practitioners as providers of minor surgery--a success story? Br J Gen Pract (1997) 1.66
Sulindac suppresses tumorigenesis in the Min mouse. Carcinogenesis (1996) 1.62
Sporadic fundic gland polyps: common gastric polyps arising through activating mutations in the beta-catenin gene. Am J Pathol (2001) 1.61
Chiari I malformation: association with hypophosphatemic rickets and MR imaging appearance. Radiology (1995) 1.61
Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Ann Surg (1996) 1.61
Rectal epithelial apoptosis in familial adenomatous polyposis patients treated with sulindac. Gut (1999) 1.59
Gene amplification of c-myc and N-myc in small cell carcinoma of the lung. Science (1986) 1.56
Dietary protein-induced colitis in breast-fed infants. J Pediatr (1982) 1.56
Pancreatic cancer cell DNA content correlates with long-term survival after pancreatoduodenectomy. Ann Surg (1991) 1.55
Vessel caliber and branch-angle of human coronary artery branch-points. Circ Res (1976) 1.55
Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences. Am J Pathol (1998) 1.55
Intravascular lymphomatosis: a clinicopathologic study of 10 cases and assessment of response to chemotherapy. J Clin Oncol (1994) 1.55
Barrett's esophagus: its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux. Am J Surg (1985) 1.53
Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors. Cancer Res (2000) 1.53
Local (immunoglobulin A) immune response by the intestine to cholera toxin and its partial suppression with combined systemic and intra-intestinal immunization. Infect Immun (1978) 1.52